Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Masimo (MASI) Cash from Discontinued Operations (2024 - 2026)

Masimo's quarterly Cash from Discontinued Operations came in at 1500000.0 in Q2 2026, up 77.94% year-on-year from 842975.21 in Q2 2025, and down 850.0% quarter-over-quarter from 200000.0 in Q1 2026.

Masimo has reported Cash from Discontinued Operations for 3 years, with the latest figure at 1500000.0 in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Discontinued Operations rose 77.94% year-over-year to 1500000.0; the trailing twelve-month figure through Apr 2026 stood at 5900000.0 (down 70.35% YoY), and the FY2026 full-year result was 600000.0, down 98.23% from the prior year.
  • Cash from Discontinued Operations for Q2 2026 stood at 1500000.0, down from 200000.0 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 23500000.0 in Q4 2024, with the low at 6800000.0 in Q1 2025.
  • Average Cash from Discontinued Operations over 3 years is 3666666.67, with a median of 200000.0 recorded in 2026.
  • Peak annual rise in Cash from Discontinued Operations reached 84.62% in 2025, while the deepest fall reached 194.44% in 2025.
  • Tracing MASI's Cash from Discontinued Operations over 3 years: stood at 23500000.0 in 2024, then plunged by 102.55% to 600000.0 in 2025, then slumped by 150.0% to 1500000.0 in 2026.
  • The last three Cash from Discontinued Operations figures came in at 1500000.0 (Q2 2026), 200000.0 (Q1 2026), and 600000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Masimo 9.32 Bn 9.20 Bn 250.80 Mn -1.50 Mn

Historic Data

Download Data 🔒
DateValue
Apr 4, 2026 -1.50 Mn
Apr 4, 2026 -1.50 Mn
Jan 3, 2026 200,000.00
Jan 3, 2026 200,000.00
Sep 27, 2025 -600,000.00
Sep 27, 2025 -600,000.00
Jun 28, 2025 7.80 Mn
Jun 28, 2025 7.80 Mn
Mar 29, 2025 -6.80 Mn
Mar 29, 2025 -6.80 Mn
Dec 28, 2024 23.50 Mn
Dec 28, 2024 23.50 Mn
Sep 28, 2024 -3.90 Mn
Sep 28, 2024 -3.90 Mn
Jun 29, 2024 7.10 Mn
Jun 29, 2024 7.10 Mn
Mar 30, 2024 7.20 Mn
Mar 30, 2024 7.20 Mn